{
  "id": 10575408,
  "title": "Monopar Therapeutics CEO Robinson sells $2.5m in stock",
  "url": "https://urgent.news/2026/09/29/monopar-therapeutics-ceo-robinson-sells-2-5m-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-29T01:15:59.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/monopar-therapeutics-ceo-robinson-sells-25m-in-stock-93CH-4921477"
  },
  "original_language": "en",
  "account": "Chandler Robinson, CEO and Director of Monopar Therapeutics (MNPR), sold $2.5 million worth of the company's stock on September 24, 2026, according to a SEC filing. The sale comprised 29,056 shares, with prices per share ranging from $87.15 to $89.79. The transactions were conducted under a Rule 10b5-1 trading plan Robinson established on June 25, 2026. Currently, the stock price stands at $83.72, down 13% in the past week but up 55% over the past six months. Analysts believe the stock is overvalued, with price targets ranging from $119 to $145. Simultaneously, Robinson purchased 29,056 shares of Monopar Therapeutics stock through the exercise of stock options, valued at approximately $631,680. This brought his direct ownership to 99,267 shares, with an additional 62,815 shares held indirectly via trust. Monopar Therapeutics has been busy with significant developments, including a rolling New Drug Application submission for ALXN1840, a Wilson disease treatment, and the appointment of three new commercial executives. However, Cantor Fitzgerald downgraded the stock to Neutral from Overweight despite raising the price target to $119. BTIG and H.C. Wainwright have also increased their price targets to $133 and $125, respectively, maintaining Buy ratings. Analysts cite the NDA filing and potential future earnings as key factors.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Meta platforms CEO Mark Zuckerberg sells $21.36m in stock",
        "url": "https://urgent.news/2026/09/29/meta-platforms-ceo-mark-zuckerberg-sells-21-36m-in-stock",
        "published": "2026-09-29T00:16:07.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}